NON SMALL CELL LUNG CARCINOMA NSCLC
Clinical trials for NON SMALL CELL LUNG CARCINOMA NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CARCINOMA NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CARCINOMA NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung cancer drug aims to outperform current standard
Disease control Recruiting nowThis study tests a new drug called SCTB14 against the standard drug pembrolizumab for people with advanced non-small cell lung cancer that has not been treated yet. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 or pembrolizumab to see which o…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC
-
Cutting chemo doses for seniors: help or harm?
Knowledge-focused Recruiting nowThis study looks at whether giving older adults (65+) with advanced lung cancer a lower dose of chemotherapy affects how long they live. Researchers will compare survival between those who received standard doses and those who got reduced doses. The goal is to find out if dose re…
Matched conditions: NON SMALL CELL LUNG CARCINOMA NSCLC
Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC